AKT1 and breast carcinoma: The investigation revealed the ability of these derivatives to potentiate therapeutic anticancer effects by targeting the PI3K/Akt/mTOR signaling pathway, which is crucial for cell signaling, proliferation, survival, and metabolism in breast cancer.